Literature DB >> 20192713

Vaccination in older adults: development of an educational tool, Vaxisenior, in France.

Joel Belmin1, Patrice Bourée, Daniel Camus, Nicole Guiso, Claude Jeandel, Christophe Trivalle, Pierre Veyssier.   

Abstract

The benefits of vaccination in older adults are well documented yet there is poor uptake of such preventive measures, and one of the main reasons in France is a lack of recommendation and support from healthcare professionals. To address this issue a multidisciplinary group of experts has developed an educational tool, Vaxisenior, to assist in the training of physicians/healthcare workers who can act as advocates for immunization programs. The tool comprises of eight sections (general introduction; immunosenescence; diphtheria-tetanus-poliomyelitis; influenza; pneumococcus; pertussis; herpes zoster; and vaccines for travelers). In addition, it includes national immunization schedules and recommendations, practical information regarding opportunities to expand vaccine coverage that is convenient to the patient and a questions and answers section covering topics relating to particular usage and responsibilities. Implementation of vaccination policies for older adults is a major issue and will require extensive promotional campaigns, as well as active support from healthcare and public health professionals to improve overall vaccine coverage.

Entities:  

Mesh:

Year:  2010        PMID: 20192713     DOI: 10.1586/erv.10.29

Source DB:  PubMed          Journal:  Expert Rev Vaccines        ISSN: 1476-0584            Impact factor:   5.217


  2 in total

Review 1.  Strategies implemented to address vaccine hesitancy in France: A review article.

Authors:  Cécile Fokoun
Journal:  Hum Vaccin Immunother       Date:  2018-06-14       Impact factor: 3.452

2.  Immunogenicity and safety results from a randomized multicenter trial comparing a Tdap-IPV vaccine (REPEVAX®) and a tetanus monovalent vaccine in healthy adults: new considerations for the management of patients with tetanus-prone injuries.

Authors:  Henri Laurichesse; Ulrich Zimmermann; Florence Galtier; Odile Launay; Xavier Duval; Patrick Richard; Christine Sadorge; Benoit Soubeyrand
Journal:  Hum Vaccin Immunother       Date:  2012-10-02       Impact factor: 3.452

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.